Mera Pharmaceuticals, Inc.
MRPI · OTC
10/31/2011 | 7/31/2011 | 4/30/2011 | 1/31/2011 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $4 | $1 | $7 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $14 | $12 | $10 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $54 | $51 | $14 | $17 |
| Property Plant & Equip (Net) | $2 | $4 | $6 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $14 | $30 | $27 | $23 |
| Total NC Assets | $16 | $34 | $33 | $28 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $71 | $85 | $46 | $44 |
| Liabilities | – | – | – | – |
| Payables | $486 | $150 | $150 | $150 |
| Short-Term Debt | $0 | $52 | $52 | $52 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $218 | $211 | $189 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $935 | $847 | $793 | $756 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $935 | $847 | $793 | $756 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $55 | $55 | $55 | $55 |
| Retained Earnings | -$8,886 | -$8,784 | -$8,768 | -$8,733 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$865 | -$762 | -$747 | -$712 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $71 | $85 | $46 | $44 |
| Net Debt | -$4 | $48 | $51 | $45 |